Prognostic Factors in Resected Pancreatic Neuroendocrine Tumours: Experience in 95 Patients
详细信息    查看全文
文摘
The aim of this study was to analyse prognostic factors for survival and recurrence in patients with resected pancreatic neuroendocrine tumours (PNT).

Methods

Medical records of 95 patients with resected PNT were retrospectively reviewed. The variables studied were: age, sex, form of presentation (sporadic/familial tumours), functionality, type of tumour, localisation, type of surgery, tumour size, multifocal tumours and recurrent rate. The new WHO classification (2010) was used.

Results

There were 45 men and 50 women. Mean age was 46.8 years. Regarding the mode of presentation, it was sporadic in 66 patients (69.8%) and 29 cases were familial neuroendocrine tumours (30.2%) in association with MEN 1 syndrome. The 59% of patients suffered from non-functional tumours and 41% were functional: 20 insulinoma, 16 gastrinoma, and 3 glucagonoma. Distal pancreatectomy was the most common surgical procedure, followed by tumour enucleation in 19 patients. According to the WHO classification, 59 patients had a PNT G1, 24 PNT G2 and 12 with a poorly-differentiated carcinoma, respectively. The 5-year survival in well-differentiated tumours was 100%, regardless of the functionality. Sporadic PNT are more commonly unifocal (P<.001), associating liver metastasis. Survival and recurrence rates after a mean follow-up of 85.3 months were 65.8% and 24%, respectively.

Conclusions

In our experience, WHO classification was an independent prognostic factor in PNT survival.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700